| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Van Heel Kenneth | Director | C/O SEASTAR MEDICAL HOLDING CORPORATION, 3513 BRIGHTON BLVD., SUITE 410, DENVER | /s/ Eric Schlorff, as attorney-in-fact | 2025-08-28 | 0001613111 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ICU | Common Stock, par value $0.0001 per share | Purchase | $22.2K | +25K | +173.61% | $0.89 | 39.4K | Aug 26, 2025 | Direct | F1 |
| transaction | ICU | Common Stock, par value $0.0001 per share | Purchase | $8.57K | +10K | +25.38% | $0.86 | 49.4K | Aug 27, 2025 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The price reported in Row 1, Column 4 is a weighted average price of $0.8899. These shares were purchased in multiple transactions at prices ranging from $0.885 to $0.89 inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
| F2 | The price reported in Row 2, Column 4 is a weighted average price of $0.8565. These shares were purchased in multiple transactions at prices ranging from $0.8531 to $0.8599 inclusive. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price. |